
Melinda G Pauly MD
Pediatric Hematologic Oncology
Assistant Professor, Pediatrics, Emory University School of Medicine Medical Director of Oncology, Aflac Cancer and Blood Disorders Center of Children’s Healthcare of Atlanta
Join to View Full Profile
2220 North Druid Hills RdSouth Tower Cl15224Atlanta, GA 30329
Phone+1 404-785-3730
Fax+1 404-785-3600
Dr. Pauly is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
 - Connect with colleagues in the same hospital or clinic.
 - Read the latest clinical news, personalized to your specialty.
 
Education & Training
Emory University School of MedicineFellowship, Pediatric Hematology/Oncology, 2009 - 2012
University of Alabama Medical CenterResidency, Pediatrics, 2005 - 2008
Medical College of Georgia at Augusta UniversityClass of 2005
Certifications & Licensure
GA State Medical License 2010 - 2027
AL State Medical License 2007 - 2009
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Brentuximab Vedotin or Crizotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II-IV Anaplastic Large Cell Lymphoma Start of enrollment: 2013 Nov 13
 - Dasatinib in Combination With Chemotherapy for Relapsed or Refractory Core Binding Factor Acute Myeloid Leukemia Start of enrollment: 2015 Dec 01
 
Publications & Presentations
PubMed
- Paired Tumor/Normal Sequencing Identifies a SEPT9::ABL1 Fusion in a Child With T-Cell Lymphoblastic Lymphoma.Miyoung Lee, Dailia B Francis, Melinda G Pauly, Ryan J Summers, Bojana Pencheva
Pediatric Blood & Cancer. 2025-11-01 - Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeu...Nirali N Shah, Eric S Schafer, Yueh-Yun Chi, Jemily Malvar, Kenneth M Heym
Pediatric Blood & Cancer. 2025-05-01 - 4 citationsAzacitidine as epigenetic priming for chemotherapy is safe and well-tolerated in infants with newly diagnosed-rearranged acute lymphoblastic leukemia: Children's Oncol...Erin M Guest, John A Kairalla, Meenakshi Devidas, Emily Hibbitts, Andrew J Carroll
Haematologica. 2024-12-01 
Abstracts/Posters
- Phase 1b Study of Carfilzomib in Combination with Induction Chemotherapy in Children with Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL)Melinda Pauly, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
 
Lectures
- Matched Targeted Therapy for Pediatric Patients with Relapsed, Refractory or High-Risk Leukemias: A Report from the LEAP ConsortiumClinically Relevant Abstract2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
 - Phase I Study of the Selinexor in Relapsed/Refractory Childhood Acute Leukemia2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
 
Press Mentions
- Children’s Healthcare of Atlanta Opens First Clinical Trial for New Therapy Targeting LeukemiaApril 12th, 2023
 
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









